We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-14.58%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.9B
AUM Growth
-$862M
Cap. Flow
-$479M
Cap. Flow %
-25.16%
Top 10 Hldgs %
43.35%
Holding
99
New
27
Increased
22
Reduced
5
Closed
11

Top Buys

Rank Stock Value
1
WSC icon
WillScot Mobile Mini Holdings
WSC
+$46.7M
2
BRSL
Brightstar Lottery PLC
BRSL
+$27.4M
3
APO icon
Apollo Global Management
APO
+$24.9M
4
COOP
Mr. Cooper
COOP
+$23.1M
5
INSM icon
Insmed
INSM
+$13.5M

Top Sells

Rank Stock Value
1
ATRS
Antares Pharma, Inc.
ATRS
+$44.7M
2
NFE icon
New Fortress Energy
NFE
+$36.8M
3
CHGG icon
Chegg
CHGG
+$33.4M
4
AIR icon
AAR Corp
AIR
+$21.6M
5
GSM icon
FerroAtlántica
GSM
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Industrials 18.53%
3 Energy 12.47%
4 Financials 10.45%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRSL
26
Brightstar Lottery PLC
BRSL
$2.07B
$23.9M 1.25%
+1,287,163
New +$27.4M
COOP
27
DELISTED
Mr. Cooper
COOP
$23.7M 1.24%
644,297
+545,508
+552% +$23.1M
IEA
28
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$22.6M 1.19%
2,810,831
+943,306
+51% +$8.82M
FREE
29
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$22.2M 1.17%
3,583,363
– –
HRT
30
DELISTED
HireRight Holdings Corporation
HRT
$21.6M 1.14%
1,523,266
– –
KPTI icon
31
Karyopharm Therapeutics
KPTI
$47.6M
$19.8M 1.04%
293,333
+52,837
+22% +$4.85M
MREO
32
Mereo BioPharma
MREO
$48.8M
$18.8M 0.99%
16,756,120
+1,756,120
+12% +$1.36M
CCO icon
33
Clear Channel Outdoor Holdings
CCO
$1.23B
$18.6M 0.98%
17,391,427
+500,000
+3% +$1.05M
DMRC icon
34
Digimarc Corp
DMRC
$172M
$17.2M 0.9%
1,214,593
+500,000
+70% +$10.3M
ITOS
35
DELISTED
iTeos Therapeutics
ITOS
$16.9M 0.89%
822,112
– –
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$16.6M 0.87%
949,166
+384,813
+68% +$6.04M
QNST icon
37
QuinStreet
QNST
$1.2B
$16M 0.84%
1,585,924
– –
TSAT icon
38
Telesat
TSAT
$905M
$15.8M 0.83%
1,410,000
– –
RNW icon
39
ReNew
RNW
$2.5B
$14.7M 0.77%
2,279,013
+1,157,347
+103% +$8.34M
CMRX
40
DELISTED
Chimerix, Inc.
CMRX
$14.7M 0.77%
7,084,604
+2,284,604
+48% +$7.34M
AVPT icon
41
AvePoint
AVPT
$2.78B
$14M 0.74%
3,230,165
– –
EVER icon
42
EverQuote
EVER
$884M
$13M 0.69%
1,475,745
– –
NGM
43
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$10.2M 0.54%
+797,588
New +$11M
EPZM
44
DELISTED
Epizyme, Inc
EPZM
$9.24M 0.49%
+6,283,690
New +$4.62M
AERI
45
DELISTED
Aerie Pharmaceuticals
AERI
$9.24M 0.49%
+1,231,483
New +$8.68M
ALEC icon
46
Alector
ALEC
$233M
$9.14M 0.48%
900,000
– –
PING
47
DELISTED
Ping Identity Holding Corp.
PING
$8.59M 0.45%
473,709
– –
MYPS icon
48
PLAYSTUDIOS Inc
MYPS
$81.1M
$8.39M 0.44%
1,961,184
– –
TXMD icon
49
TherapeuticsMD
TXMD
$24M
$7.88M 0.41%
791,831
+684,945
+641% +$6.54M
NRDY icon
50
Nerdy
NRDY
$95M
$7.35M 0.39%
3,450,406
– –
1
2
3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Rubric Capital Management (New York) held 99 positions worth $1.9B, down 31% from $2.77B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rubric Capital Management (New York) withdrew a net $479M in Q2 2022, closing 11 positions and reducing 5 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 14% a quarter earlier, followed by Industrials and Energy.

Against the trend, Rubric Capital Management (New York) opened a new position in WillScot Mobile Mini Holdings worth $42.8M.

  • Rubric Capital Management (New York)'s largest Q2 2022 buy was WillScot Mobile Mini Holdings: 1,320,713 shares worth $42.8M.
  • Rubric Capital Management (New York) added most to Apollo Global Management in Q2 2022, an estimated $24.9M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2022 reduction was New Fortress Energy, cutting an estimated $36.8M.
  • Rubric Capital Management (New York) fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $44.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 43% of its $1.9B portfolio in Q2 2022.
  • Rubric Capital Management (New York) opened 27 new positions and closed 11 in Q2 2022.
  • Rubric Capital Management (New York)'s portfolio value fell 31% quarter-over-quarter to $1.9B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2022, filed 12 Aug 2022.